FDA Inspection 1135594 — Sagar Sardesai, M.D.

Sagar Sardesai, M.D. — FEI 3017666994

The FDA completed an inspection of Sagar Sardesai, M.D. on February 12, 2021 in Columbus, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbus, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752021 CFR 312.64(b)Safety reports